Franco D. Doimi
Lima, LMA, Peru
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru.
Journal: Frontiers in oncology
Published: May 23, 2023
Status of breast cancer in Latin American: Results of the breast cancer revealed initiative.
Journal: Critical reviews in oncology/hematology
Published: September 08, 2022
Prognostic Capability of TNBC 3-Gene Score among Triple-Negative Breast Cancer Subtypes.
Journal: Cancers
Published: July 15, 2022
Recommendations for streamlining precision medicine in breast cancer care in Latin America.
Journal: Cancer reports (Hoboken, N.J.)
Published: February 21, 2021
Correction: RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 17, 2019
Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer.
Journal: Scientific reports
Published: September 20, 2017
Automated segmentation and classification of cell nuclei in immunohistochemical breast cancer images with estrogen receptor marker.
Journal: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
Published: March 09, 2017
Herbal Medicine Practices of Patients With Liver Cancer in Peru: A Comprehensive Study Toward Integrative Cancer Management.
Journal: Integrative cancer therapies
Published: January 17, 2017
Repeated observation of immune gene sets enrichment in women with non-small cell lung cancer.
Journal: Oncotarget
Published: November 19, 2015
Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials.
Journal: Breast cancer research and treatment
Published: September 24, 2015
Last Updated: 09/26/2026